Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2016 Annual Report on Form 10-K - PDF 2016 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$15.36
Change (%) Stock is Up 0.07 (0.46%)
Volume83,818
Data as of 06/23/17 1:06 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
06/22/17OraSure Technologies Appoints Mara G. Aspinall to Board of Directors
BETHLEHEM, Pa., June 22, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Ms. Mara G. Aspinall as a member of the Company's Board of Directors.  Ms. Aspinall will serve as a Class II Director with an initial term expiring at the Company’s 2020 Annual Meeting of Stockholders.  She will also serve on the Audit and Compensation Committees of the Board. "We are please... 
Printer Friendly Version
05/31/17OraSure Technologies to Present at the Jefferies 2017 Global Healthcare Conference
BETHLEHEM, Pa., May 31, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Jefferies 2017 Global Healthcare Conference in New York, New York.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on June 7, 2017, at approximately 8:30 AM Eastern Time ... 
Printer Friendly Version
05/16/17OraSure Technologies to Present at the UBS Global Healthcare Conference
BETHLEHEM, Pa., May 16, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS Global Healthcare Conference in New York, New York.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on May 23, 2017, at approximately 8:30 AM Eastern Time (5:30 AM Pa... 
Printer Friendly Version
05/10/17OraSure Technologies to Hold Virtual Annual Meeting of Stockholders
BETHLEHEM, Pa., May 10, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), announced that its 2017 Annual Meeting of Stockholders will again be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) on Tuesday, May 16, 2017. In order to access the meeting, interested parties may go to www.virtualshareholdermeeting.com/OSUR2017 five (5) minutes prior to the start of the meeting to log in.  Stockholders must enter ... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet